Skip to content

OptimizeRx OPRX Free cash flow margin

Free cash flow margin at other companies

Phreesia logo
PhreesiaPHR
15.3%+6.9pp
Doximity logo
DoximityDOCS
50.6%+2.7pp
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
21%+2.3pp
PubMatic logo
PubMaticPUBM
24.8%+8.7pp
National Research Corporation logo
National Research CorporationNRC
12.6%+2.0pp
Fluent, Inc. logo
Fluent, Inc.FLNT
-3%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

Based on trailing twelve months.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's free cash flow margin?
OptimizeRx (OPRX) reported free cash flow margin of 13.4% in Q1 2026.
How has OptimizeRx's free cash flow margin changed year-over-year?
OptimizeRx's free cash flow margin increased by 57.0% year-over-year, from 8.5% to 13.4%.
What is the long-term trend for OptimizeRx's free cash flow margin?
Over 3 years (2020 to 2025), OptimizeRx's free cash flow margin has grown at a 4.4% compound annual growth rate (CAGR), from -15% to 17%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.